Browsing Master in Pharmacy by Subject "acute respiratory distress syndrome (ARDS)"
Now showing items 1-1 of 1
-
Ethanol-Based Proliposomes Incorporating Dexamethasone for The Treatment of COVID-19 Acute Respiratory Distress Syndrome (ARDS) Using Medical Nebulizers
(2023 , Master Thesis)Background/Objective: Systemic dexamethasone has demonstrated mortality reduction in COVID-19-related acute respiratory distress syndrome (ARDS). The aim of this study is to use ethanol-based proliposome technology to ...